Attending #ASH25? Stop by booth \#2161 to meet the ICON team and discuss how our extensive testing capabilities, clinical research experience and scientific expertise can support global oncology and haematology research ...
From bottlenecks to breakthroughs
Human-centred strategies for faster study starts
Read the whitepaperOptimising vaccine follow-up through early planning
A proactive approach to RWD and tokenisation integration
Read the whitepaperDeveloping AI in software as a medical device (SaMD)
Model and data selection best practices
Read the whitepaperInvesting in Anti-HIV
How HIV therapeutic developers can reshape the future of HIV control
Read the whitepaper
Featured solutions
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Webinars
Becoming a sponsor of choice for high-performing sites
3 December 2025. Register now.
Riding the data wave: How pharma can navigate disruptions in open claims
8 December 2025. Register now.
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
16 December 2025. Register now.